APP and early-onset autosomal dominant Alzheimer disease: al. [21] have declared the phosphorylation of amyloid precursor protein (APP) is one of the keys for modulating the generation of amyloid-β and phosphorylation abnormalities of APP would lead to abnormal accumulation of amyloid-β in the central nervous system, which is a hallmark of Alzheimer’s disease.